BLUE stock gains as earnings update draws upgrade at Barclays (NASDAQ:BLUE)
The shares of bluebird bio rose in the morning hours Friday after Barclays upgraded the gene therapy developer to Equal Weight from Underweight following the company’s 2Q 2022…
BLUE stock gains as earnings update draws upgrade at Barclays (NASDAQ:BLUE)
The shares of bluebird bio rose in the morning hours Friday after Barclays upgraded the gene therapy developer to Equal Weight from Underweight following the company’s 2Q 2022…